Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab

This study has been terminated.
(Low enrollment)
Sponsor:
Collaborators:
GlaxoSmithKline
Cephalon
Information provided by:
Nevada Cancer Institute
ClinicalTrials.gov Identifier:
NCT01125787
First received: May 14, 2010
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)